EDMONTON, Alberta, April 27 /PRNewswire/ -- Medical Services International Inc. (OTC:MSITF) is pleased to announce that the sale of VScan rapid test kits continues to grow. For the first three months in 2006 the Company has sold 726,000 test kits at an average price of $2.21 US per kit. The company has confirmed orders for 1.35 million kits over the next 16 months and is currently negotiating orders totaling 3.6 million kits. The orders that are currently being filled are primarily for HIV test kits. The Company is also filling orders for Dengue, Malaria, Hepatitis C and Tuberculosis (TB) test kits. The Company continues to apply for regulatory approvals of its test kits in all countries where market studies show that there is a large potential market. About VScan The VScan rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright